ScholarIQanswers from OpenAlex & ORCID
Nicole M. Kuderer
ResearcherPublications, citations & collaboration network
Nicole M. Kuderer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nicole M. Kuderer have?
ScholarIQindexed works
Nicole M. Kuderer has 241 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nicole M. Kuderer have?
ScholarIQcitation count
Nicole M. Kuderer has 24,279 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nicole M. Kuderer?
ScholarIQh-index
Nicole M. Kuderer has an h-index of 54 in OpenAlex.
What is the i10-index of Nicole M. Kuderer?
ScholarIQi10-index
Nicole M. Kuderer has an i10-index of 104 in OpenAlex.
What is the ORCID of Nicole M. Kuderer?
ScholarIQorcid
The ORCID for Nicole M. Kuderer is on the source record.
What is the OpenAlex record for Nicole M. Kuderer?
ScholarIQopenalex
The OpenAlex for Nicole M. Kuderer is on the source record.
What are the most-cited papers on Nicole M. Kuderer?
ScholarIQmost cited works
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih–Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros Grivas, Corrie Painter, Solange Peters, Michael A Thompson, Ziad Bakouny, Gerald Batist, Tanios Bekaii‐Saab, Mehmet Asım Bilen, Nathaniel Bouganim, Mateo Bover Larroya, Daniel Castellano, Salvatore A. Del Prete, Deborah B. Doroshow, Pamela Egan, Arielle Elkrief, Dimitrios Farmakiotis, Daniel Flora, Matthew D. Galsky, Michael Glover, Elizabeth A. Griffiths, Anthony P. Gulati, Shilpa Gupta, Navid Hafez, Þorvarður R. Hálfdánarson, Jessica E. Hawley, Emily Hsu, Anup Kasi, Ali Raza Khaki, Christopher A. Lemmon, Colleen Lewis, Barbara Logan, Tyler Masters, Rana R. McKay, Ruben A. Mesa, Alicia K. Morgans, Mary F. Mulcahy, Orestis A. Panagiotou, Prakash Peddi, Nathan A. Pennell, Kerry L. Reynolds, L Rosen, Rachel Rosovsky, Mary Salazar, Andrew Schmidt, Sumit Shah, Justin Shaya, John A. Steinharter, Keith Stockerl‐Goldstein, Suki Subbiah, Donald C. Vinh, Firas Wehbe, Lisa B. Weissmann, Julie Wu, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Albert C. Yeh, Peter Paul Yu, Alice Y. Zhou, Leyre Zubiri, Sanjay Mishra, Gary H. Lyman, Brian I. Rini, Jeremy L. Warner, Maheen Z. Abidi, Jared D. Acoba, Neeraj Agarwal, Syed A. Ahmad, Archana Ajmera, Jessica K. Altman, Anne H. Angevine, Nilo Azad, Michael Bär, Aditya Bardia, Jill S. Barnholtz‐Sloan, Briana Barrow, Babar Bashir, Rimma Belenkaya, Stephanie Berg, Eric Bernicker, Christine M. Bestvina, Rohit Bishnoi, Genevieve M. Boland, Mark Bonnen, Gabrielle Bouchard, Daniel W. Bowles, Fiona Busser, Angelo Cabal, Paolo F. Caimi, Theresa M. Carducci, Carla Casulo
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar, Saroj Vadhan‐Raj, Hanno Riess, Ted Wun, Michael B. Streiff, David García, Howard A. Liebman, Chandra P. Belani, Eileen M. O’Reilly, Jai N. Patel, Habte Yimer, Peter Wildgoose, Paul Burton, Ujjwala Vijapurkar, Simrati Kaul, John W. Eikelboom, Robert D. McBane, Kenneth A. Bauer, Nicole M. Kuderer, Gary H. Lyman
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
Fabrice André, Nofisat Ismaila, N. Lynn Henry, Mark R. Somerfield, Robert C. Bast, William E. Barlow, Deborah Collyar, M. Elizabeth Hammond, Nicole M. Kuderer, Minetta C. Liu, Catherine Van Poznak, Antonio C. Wolff, Vered Stearns